Annual Report 2019

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2019 159 The United Laboratories International Holdings Limited Annual Report 2019 48. EVENTS AFTER THE REPORTING PERIOD (a) Impact of Novel Coronavirus (“COVID-19”) to the Group Since January 2020, the outbreak of Novel Coronavirus (“COVID-19”) has impacts on the global business environment. Up to the date of authorisation for issue of financial statements, COVID-19 has not resulted in material impact to the Group’s operations. In spite of effect of COVID-19, most of the factories of the Group remained normal manufacturing activities after its Chinese New Year holiday. The management at present expects that there should be no material adverse impact to the Group’s financial position and operations for the year 2020. The Group will keep continuous attention on the situation of the COVID-19 and react actively to its impact on the financial position and operations of the Group. (b) Repayment of Corporate Bonds Subsequent to the end of reporting period, Corporate bonds of RMB1,095,418,000 as set out in Note 31 was fully repaid on 24 February 2020. (c) Conversion of Convertible Bonds Subsequent to the end of reporting period, the Company received a notice from a bondholder for the conversion of bonds with principal amount of USD2,224,000 (equivalent to approximately RMB17,250,000) into 3,654,663 ordinary shares of HK$0.01 each at a conversion price of HK$4.72 per conversion share.